Search results
Results from the WOW.Com Content Network
The treatment for recently developed or acute hepatic artery thrombosis include anticoagulant medications, fibrinolytic therapy to break up the blood clot, or surgical revascularization. [2] If acute hepatic artery thrombosis occurs after liver transplantation, then retransplantation with a new liver may be necessary.
Thromboembolism is a condition in which a blood clot breaks off from its original site and travels through the bloodstream (as an embolus) to obstruct a blood vessel, causing tissue ischemia and organ damage. Thromboembolism can affect both the venous and arterial systems, with different clinical manifestations and management strategies.
Treatment of acute ischemia may include stenting or medications to break down the clot provided at the site of obstruction by interventional radiology. [1] Open surgery may also be used to remove or bypass the obstruction and may be required to remove any intestines that may have died. [2] If not rapidly treated outcomes are often poor. [1]
Other symptoms may include abdominal pain, shortness of breath, pale skin, or passing out. [1] [9] Sometimes in those with small amounts of bleeding no symptoms may be present. [1] Bleeding is typically divided into two main types: upper gastrointestinal bleeding and lower gastrointestinal bleeding. [2]
Blood clot: Diagram of a thrombus (blood clot) that has blocked a vein valve: Specialty: Vascular surgery: Symptoms: abrupt change in mental status, chest pain, cramp-like feeling, fatigue, passing out , and swelling in the arm and/or leg: Complications: bleeding risks from taking anticoagulants, breathing problems, heart attacks, stroke: Duration
The diagnosis of portal vein thrombosis is usually made with imaging confirming a clot in the portal vein; ultrasound is the least invasive method and the addition of Doppler technique shows a filling defect in blood flow. PVT may be classified as either occlusive or nonocclusive based on evidence of blood flow around the clot. [5]
Plasmin is produced in the blood to break down fibrin, the major constituent of blood thrombi, thereby dissolving clots once they have fulfilled their purpose of stopping bleeding. Extra production of plasmin caused by streptokinase breaks down unwanted blood clots, for example, in the lungs (pulmonary embolism).
Budd–Chiari syndrome is a very rare condition, affecting one in a million adults. [1] [2] The condition is caused by occlusion of the hepatic veins (usually due to a blood clot) that drain the liver. The symptoms are non-specific and vary widely, but it may present with the classical triad of: abdominal pain, ascites, and; liver enlargement.